Option chain shows key data for PainReform's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for PainReform.

PainReform (NASDAQ:PRFX) Stock, Option Chain

PainReform

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Crude Oil and Petroleum Trade in the Crosshairs

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

PRFX

PTPI

SEPN

SMCI

Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

BPTH

HCTI

US Stocks Mixed; NY State Business Activity Rises In February

Wall Street

Intraday Update

GALT

HSDT

MYSZ

TAOP

Dow Surges 100 Points, Carnival Earnings Top Views

PainReform Ltd

Press Releases

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

Health Care

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

"Stocks Under $1 to Watch: SOAR, PRFX, NCNC, BTTC, RJDG—Breakthroughs, Surges, Market Movers!"

General

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

"Power Nickel (TSX.V: PNPN) (OTCQB: PNPNF) Announces Dividend – MIGI, PRFX, PBM, CSDX Stocks Trending Now!"

Early Santa Claus Rally Highlights Power Nickel Inc. (TSXV: PNPN) and Other Stocks to Watch Now!

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics

Comments

PainReform

PainReform (PRFX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga